The Circulating Tumor DNA (ctDNA) market was valued at USD 19.76 Billion in 2024 and is expected to reach USD 69.40 Billion by 2032, growing at a CAGR of 17% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.